Journal article icon

Journal article

Vagus nerve stimulation as a potential treatment for acute asthmatic bronchoconstriction: a systematic review

Abstract:

Objective

Vagus nerve stimulation (VNS) is a therapeutic option for diseases such as epilepsy and depression. Given that the smooth muscle of the bronchi is innervated by the vagus nerve, VNS could aid in treating pathologies of the respiratory system involving a bronchoconstrictive component. The aim of this review is to evaluate the literature on the potential for VNS to relieve airway bronchoconstriction in asthma.

Methods

A systematic review of several databases (PubMed, Embase and Scopus) was conducted according to the PRISMA guidelines. Studies of individuals (humans and animals) with asthma symptoms were included if they reported respiratory function outcomes. Two authors independently reviewed all papers for selection, methodological assessment, and data extraction.

Results

A total of 2072 articles were identified, of which 1,528 unique articles were screened for inclusion. 30 relevant articles underwent full-text review, and six articles (four in humans; two in animals) were included. One human article was subsequently added manually due to a new finding in an updated search. Due to incomplete data reporting, meta-analysis was not possible. In both animal studies, low-voltage VNS improved respiratory function following a histamine or acetylcholine challenge. In human studies (one case report, two prospective interventional cohort studies, one randomized controlled study), VNS, in addition to standard-of-care anti-asthmatic therapy, appears to temporarily improve respiratory function.

Conclusion

Limited low-quality evidence suggests low-voltage VNS appears to reduce bronchoconstriction in both animal and human subjects. Given concerns about translatability, the absence of a control group in most studies, and the concomitant use of anti-asthmatic pharmacotherapy, it is not possible to draw conclusions about the true magnitude of VNS's effect on respiratory function and acute asthma progression. Well-designed randomized controlled trials (RCT) are needed to further evaluate the effectiveness of VNS in treating acute asthmatic bronchoconstriction and to better understand its underlying therapeutic mechanisms.
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Files:
Publisher copy:
10.3389/fphys.2025.1625871

Authors

More by this author
Role:
Author
ORCID:
0000-0001-5096-0614
More by this author
Role:
Author
ORCID:
0000-0001-9896-1616
More by this author
Role:
Author
ORCID:
0000-0003-2079-6125


Publisher:
Frontiers Media
Journal:
Frontiers in Physiology More from this journal
Volume:
16
Pages:
1625871-1625871
Publication date:
2025-08-13
DOI:
EISSN:
1664-042X
ISSN:
1664-042X


Language:
English
Keywords:
Pubs id:
2289919
Local pid:
pubs:2289919
Source identifiers:
W4413179766
Deposit date:
2026-05-08
ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP